Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05961189 · ClinicalTrials.gov registry record · Early Phase 1
Influence of Short-Term Antibiotic Therapy on Exercise
A Early Phase 1 study of Exercise and Gastrointestinal Microbiome, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 40
- Enrollment target
- 2
- Study locations
NCT05961189 is a Early Phase 1 study of Exercise and Gastrointestinal Microbiome that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 40 participants, below the 8,910-participant average among 57 other Exercise trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05961189, a Early Phase 1 study of Exercise and Gastrointestinal Microbiome, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 40 participants
- Enrollment target
- 2
- Study locations
Study Summary
The gut microbiome refers to the trillions of bacteria that inhabit the stomach and other regions involved in the digestion of food, including the intestines. Compelling studies of animals (rodents) suggest that the health of the gut microbiome may influence skeletal muscle function and exercise performance. To date, there have been no similar observations reported in humans. A common experimental approach in animal studies to temporarily disrupt the gut microbiome is through the use of antibiotic therapies. Azithromycin is an antibiotic medicine prescribed to humans for the treatment of mild to moderate infections caused by bacteria. The purpose of the proposed project is to determine the influence of short-term (5-days) antibiotic therapy (azithromycin) on exercise performance in young, healthy adults. Treadmill exercise performance will be compared in two groups of adults before and after 5-days ingestion of azithromycin, or a placebo (something that has no physical effect).
Conditions Studied
Interventions
- DRUG Azithromycin
Study Locations (2)
Colorado
- Human Performance Clinical Research Lab - Fort Collins
New Jersey
- Nutrition, and Exercise Metabolism Lab - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2025-12-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05961189
The ClinicalTrials.gov registry entry for NCT05961189 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 8,910-participant average among 57 other Exercise trials with a reported enrollment target (100% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Exercise appearing as the primary indexed condition, and to 1 intervention - of which Azithromycin is the first listed.
NCT05961189 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Colorado, New Jersey.
Frequently Asked Questions
What is clinical trial NCT05961189 about?
NCT05961189 is a clinical study titled "Influence of Short-Term Antibiotic Therapy on Exercise". The gut microbiome refers to the trillions of bacteria that inhabit the stomach and other regions involved in the digestion of food, including the intestines. Compelling studies of animals (rodents) suggest that the health of the gut microbiome may influence skeletal muscle function and exercise per...
What is the current status of trial NCT05961189?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 40 participants. The study started on 2023-09-01. Estimated completion is 2025-12-01.
What conditions does trial NCT05961189 study?
This clinical trial studies the following conditions: Exercise, Gastrointestinal Microbiome.
What interventions are being tested in trial NCT05961189?
The interventions under investigation include: Azithromycin (DRUG).
Who is sponsoring clinical trial NCT05961189?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05961189 being conducted?
This trial has 2 study locations across Colorado, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Exercise
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Response to Exercise and Nitric Oxide in PAD
RECRUITING · Phase 2
-
Goal Setting to Promote Physical Activity Adherence in Midlife Adults
RECRUITING · NA
-
Better Lifestyle Counseling for African American Women During Pregnancy
RECRUITING · NA
-
Developing a Nutritional Supplement to Increase Collagen Synthesis in People
RECRUITING · NA
-
Fasted vs. Fed State Exercise
RECRUITING · Phase 2
-
Postnatal Exercise to Activate Baby's Brown Fat
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.